<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696445</url>
  </required_header>
  <id_info>
    <org_study_id>NL71713.100.20</org_study_id>
    <secondary_id>2020-001462-10</secondary_id>
    <nct_id>NCT04696445</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Morphine and Oxycodone in Frail Elderly Undergoing Cardiac Surgery</brief_title>
  <official_title>Pharmacokinetics of Morphine and Oxycodone in Frail Elderly Undergoing Cardiac Surgery - AGE AWARE II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Antonius Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Antonius Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Single centre observational cohort study.&#xD;
&#xD;
        -  20 older patients undergoing cardiac surgery who receive standard of care pain&#xD;
           treatment.&#xD;
&#xD;
        -  Postoperative ICU: blood sampling to determine morphine and metabolite (M3G, M6G,&#xD;
           noroxycodone and oxymorphone) pharmacokinetics&#xD;
&#xD;
        -  After ICU discharge on general ward: blood sampling to determine morphine, oxycodone and&#xD;
           metabolite (M3G, M6G, noroxycodone and oxymorphone) pharmacokinetics&#xD;
&#xD;
        -  During study monitoring of pain scores, total opioid consumption, side effects (e.g.&#xD;
           nausea, vomiting, pruritus), sedation and delirium scores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain after cardiac surgery in elderly patients is common and leads to&#xD;
      postoperative complications. Opioids play an important role in treatment of postoperative&#xD;
      pain after cardiac surgery. In frail elderly after cardiac surgery however dosing schemes for&#xD;
      opioids are still unknown, potentially leading to inadequate treatment of pain and/or safety&#xD;
      issues.&#xD;
&#xD;
        -  Single center observational cohort study&#xD;
&#xD;
        -  The study population includes frail patients ≥70 years undergoing elective cardiac&#xD;
           surgery.&#xD;
&#xD;
        -  Primary endpoints of this study is the concentration of morphine, oxycodone and&#xD;
           metabolites in blood over time on behalf of pharmacokinetic modelling.&#xD;
&#xD;
        -  Secondary endpoints of this study are the pharmacodynamic parameters of morphine,&#xD;
           oxycodone and metabolites (M3G, M6G, noroxycodone and oxymorphone) in blood in frail&#xD;
           patients; such as pain scores, postoperative opioid consumption, vital signs, side&#xD;
           effects of opioids and the influence of covariates such as frailty, serum creatinine,&#xD;
           Glomerular Filtration Rate (GFR) on the pharmacokinetics and pharmacodynamics of&#xD;
           morphine and oxycodone.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>M3G concentration in blood over time</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Analysis of serum concentrations of M3G, metabolite of morphine, for pharmacokinetic modelling</description>
  </primary_outcome>
  <primary_outcome>
    <measure>M6G concentration in blood over time</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Analysis of serum concentrations of M6G, metabolite of morphine, for pharmacokinetic modelling</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Noroxycodone concentration in blood over time</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Analysis of serum concentrations of Noroxycodone, metabolite of oxycodone, for pharmacokinetic modelling</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxymorphone concentration in blood over time</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Analysis of serum concentrations of Oxymorphone, metabolite of oxycodone, for pharmacokinetic modelling</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale (NRS; 0-10, 0 = none, 10 = severe)</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>NRS as pain measurement scale, reported by nurse in standard care, for pharmacodynamic modelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Postoperative opioid consumption, mg per 24 hour, for pharmacodynamic modelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects of opioids</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Side effects of opioids (pruritis, vomiting, constipation, nausea), dichotomous (yes/no) each day by nurse/researcher, for pharmacodynamic modelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital sign observation: bloodpressure (in mmHg) by nurse</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Systolic and diastolic bloodpressure (SBP, DBP), reported by nurse in standard care for pharmacodynamic modelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital sign observation: heartrate (in beats/minute) by nurse</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Heartrate (HR) reported by nurse in standard care for pharmacodynamic modelling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital sign observation: saturation (in %) by nurse</measure>
    <time_frame>Until three consecutive days after ICU discharge</time_frame>
    <description>Saturation (SpO2), reported by nurse in standard care for pharmacodynamic modelling</description>
  </secondary_outcome>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Opioid Use</condition>
  <condition>Side Effect of Drug</condition>
  <condition>Postoperative Pain</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine &amp; Oxycodone</intervention_name>
    <description>Morphine and Oxycodone are used in daily practice as part of standard care. Morphine and Oxycodone will be acquired through the clinical pharmacy of St Antonius and administered according to the standard postoperative pain protocol.</description>
    <other_name>Morphine HCl CF 10mg/mL solution for injection / infusion</other_name>
    <other_name>OxycodoneHCl G.L. tablet 5/10mg.</other_name>
    <other_name>OxycodoneHCl Retard Lannacher 5/10/20 mg.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population includes 20 patients ≥70 years undergoing elective cardiac surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥70 years undergoing elective cardiac surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing transcatheter aortic valve replacement or mitral valve repair&#xD;
&#xD;
          -  Contra-indication for morphine and/or oxycodone&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Noordzij, Dr</last_name>
    <phone>0031883202304</phone>
    <email>p.noordzij@antoniusziekenhuis.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Antonius hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Noordzij, PhD</last_name>
      <email>p.noordzij@antoniusziekenhuis.nl</email>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Antonius Hospital</investigator_affiliation>
    <investigator_full_name>dr. P. Noordzij</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Plan to Share IPD: Undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

